$Therapy for Relapsed and Refractory Pediatric Hodgkin Lymphoma$
QR Code

QR Code

Therapy for Relapsed and Refractory Pediatric Hodgkin Lymphoma

None

Saved in:

Bibliographic Details
Main Authors:	Fernández, Karen S., Alarcón, Pedro A. de
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/33676
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evolving Therapies in Relapsed and Refractory Hodgkin Lymphoma
by: Pukiat, Sulada, et al.
Published: (2012)

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01)

CLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF PEDIATRIC RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMAS
by: T. T. Valiev
Published: (2018-07-01)

Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis
by: Mohamed Nazem Alibrahim, et al.
Published: (2025-05-01)

Optimizing therapy for relapsed/refractory classic Hodgkin lymphoma in the era of PD‐1 blockade
by: Thomas M. Kuczmarski, et al.
Published: (2025-05-01)

Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis
by: Magdalena Witkowska, et al.
Published: (2025-01-01)

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA
by: G. R. Khachatryan, et al.
Published: (2016-04-01)

Survivorship in Hodgkin Lymphoma
by: Lunning, Matthew A., et al.
Published: (2012)

State of the Art Therapy of Advanced Hodgkin Lymphoma
by: Fesler, Mark J.
Published: (2012)

Epidemiology of Hodgkin's Lymphoma
by: Al-Tonbary, Youssef
Published: (2012)

EXPERIENCE IN THE TREATMENT OF REFRACTORY HODGKIN’S LYMPHOMA
by: A. M. Chervontseva, et al.
Published: (2021-03-01)

Treatment of Early Stage Hodgkin Lymphoma
by: Srour, Samer A., et al.
Published: (2012)

Impact of Hematopoietic Stem Cell Transplantation on PD-1 Blockade Efficacy in Relapsed/Refractory Hodgkin’s Lymphoma
by: Filomena Emanuela Laddaga, et al.
Published: (2025-04-01)

Recent Insights into the Biology of Hodgkin's Lymphoma
by: Banerjee, Diponkar
Published: (2012)

Toxic Effects of Hodgkin Lymphoma Treatment
by: Hafizović, Alma Sofo
Published: (2012)

Risk-Stratified and Response-Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience
by: David Veron, et al.
Published: (2025-01-01)

The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study
by: Diana-Marina FORTOES, et al.
Published: (2025-06-01)

Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma
by: N. A. Avxentyev, et al.
Published: (2020-12-01)

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
by: Hongjuan Dong, et al.
Published: (2025-07-01)

Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study
by: Ya. V. Krylova, et al.
Published: (2024-09-01)

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience
by: K. V. Lepik, et al.
Published: (2019-01-01)

Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma
by: Matthew Mei, et al.
Published: (2025-05-01)

Treatment of pediatric relapsed and refractory acute myeloid leukemia
by: F. A. Makhacheva, et al.
Published: (2023-05-01)

Hodgkin's Lymphoma: From Tumor Microenvironment to Immunotherapeutic Approach - Body's Own Power Protection Challenges
by: Lejeune, Marylène, et al.
Published: (2012)

The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice.
by: I. A. Kamaeva, et al.
Published: (2021-06-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

New approaches for combined therapy of Hodgkin's lymphoma
by: P. V. Dacenko, et al.
Published: (2022-11-01)

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
by: Evgenii Shumilov, et al.
Published: (2025-08-01)

Results of longstanding, single-center trial for pediatric Hodgkin lymphoma treatment
by: T. T. Valiev, et al.
Published: (2021-09-01)

Advances in Classical Hodgkin Lymphoma Biology: New Prognostic Factors and Outcome Prediction Using Gene Expression Signatures
by: Sánchez-Espiridión, Beatriz, et al.
Published: (2012)

ORBITAL NON-HODGKIN’S LYMPHOMAS
by: S. V. Saakyan, et al.
Published: (2015-04-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Refractory Angina Pectoris: Focus on Cell Therapy
by: Pompilio, Giulio, et al.
Published: (2011)

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis
by: Alexander Biederstädt, et al.
Published: (2025-07-01)

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia
by: Jean-Marie Michot, et al.
Published: (2025-07-01)

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
by: Margaret Hux, et al.
Published: (2016-10-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma
by: A. M. Chekalov, et al.
Published: (2022-11-01)

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study
by: Evgenii Shumilov, et al.
Published: (2025-08-01)

Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.
by: Ya-Ting Yang, et al.
Published: (2016-01-01)